Rhabdomyosarcoma—Child
Condition
Definition
Rhabdomyosarcoma is cancer in muscle cells. It is most common in children aged 1 to 5 years old and 10 to 18 years old.
There are 3 main types:
- Embryonal—more often in the head, neck, or genital and urinary organs (most common)
- Alveolar—more often in the arms, legs, chest, belly, or genital or anal areas
- Anaplastic—rarely happens in children
Causes
Cancer is when cells in the body split without control or order. These cells go on to form a growth or tumor. Cancer refers to harmful growths. These growths attack nearby tissues and can spread to other parts of the body. It is not clear exactly what causes these problems. It is likely a mix of genes and the environment.
Copyright © Nucleus Medical Media, Inc.

Risk Factors
A child's risk of rhabdomyosarcoma are higher if they have:
- Li-Fraumeni syndrome
- Neurofibromatosis type 1
- Beckwith-Wiedemann syndrome
- Costello syndrome
- Noonan syndrome
Babies may have an increased risk for embryonal rhabdomyosarcoma if the baby:
- Has high birth weight
- Is larger than expected
Symptoms
In the early stages, the cancer is small and does not cause symptoms. A growing tumor may start to push on nearby structures. Problems depend on where the tumor is such as:
- Head—stuffy nose or sinuses that drain, facial paralysis, or a hoarse voice
- Eye—may make the eyes stick out or appear larger, and affect eye sight
- Lung—may cause coughing and breathing problems
- Bladder or bowel—may cause belly pain, vomiting, constipation, or problems passing urine
- Uterus—may cause bleeding or discharge from the vagina, and pain in the pelvis or lower part of the belly
The child may also feel tired or ill and have weight loss.
Diagnosis
The doctor will ask about the child’s symptoms and past health. The child may also have:
- A physical exam
- Blood tests
- Urine tests
- Tests on their genes
- Imaging tests such as:
- Biopsy —a sample of tissue is tested in a lab
The exam and test results will help find out the stage of cancer. Rhabdomyosarcoma is staged from 1 to 4. Stage 1 is a very localized cancer. Stage 4 is a spread to other parts of the body.
Treatment
Treatment depends on the stage. More than one method is used. Options include:
- Surgery—to remove the tumor and nearby tissue. Nearby lymph nodes may also be removed at the same time.
- Radiation therapy—to kill cancer cells and shrink tumors. Radiation is aimed at the tumor from a source outside the body. It is mainly used after surgery.
- Chemotherapy—uses drugs to kill cancer cells. It may be given by mouth, shots, or IV. It is used when the cancer has spread to other parts of the body. This will slow the pace of the disease but will not cure it.
Prevention
There are no guidelines to prevent rhabdomyosarcoma.
America Cancer Society
National Cancer Institute
CANADIAN RESOURCES:
Canadian Cancer Society
Health Canada
America Cancer Society
National Cancer Institute
CANADIAN RESOURCES:
Canadian Cancer Society
Health Canada
References
- Borinstein SC, Steppan D, et al. Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer. 2018;65(2).
- General information about childhood rhabdomyosarcoma. National Cancer Institute website. Available at: http://www.cancer.gov/types/soft-tissue-sarcoma/patient/rhabdomyosarcoma-treatment-pdq.
- Rhabdomyosarcoma. American Cancer Society website. Available at: https://www.cancer.org/cancer/rhabdomyosarcoma.html.
- Rhabdomyosarcoma in children. Cincinnati Children’s website. Available at: https://www.cincinnatichildrens.org/health/r/rhabdomyosarcoma.
- Rhabdomyosarcoma in children. EBSCO DynaMed website. Available at:https://www.dynamed.com/condition/rhabdomyosarcoma-in-children.
Contributors
- Mohei Abouzied, MD, FACP
(C) Copyright 2023 EBSCO Information Services
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com.